|
Q1 2025
|
34 |
66,155 |
NOTE, SOHU, DADA, YY
|
13F-HR
|
5/9/2025 |
000169809325000005 |
|
Q4 2024
|
34 |
79,155 |
NOTE, YY, SOHU, 217A.SG
|
13F-HR
|
2/12/2025 |
000169809325000004 |
|
Q3 2024
|
36 |
106,759 |
NOTE, SOHU, YY, EQV VENTURES ACQUISITION COR
|
13F-HR
|
11/4/2024 |
000169809324000008 |
|
Q2 2024
|
28 |
95,969 |
NOTE, SOHU, YY, 217A.SG
|
13F-HR
|
8/13/2024 |
000169809324000005 |
|
Q1 2024
|
36 |
135,260 |
NOTE, HOLI, YY, SOHU
|
13F-HR
|
5/9/2024 |
000169809324000004 |
|
Q4 2023
|
27 |
115,713 |
NOTE, HOLI, YY, SOHU
|
13F-HR
|
2/14/2024 |
000169809324000001 |
|
Q3 2023
|
37 |
183,560 |
NOTE, CD, HOLI, YY
|
13F-HR
|
11/13/2023 |
000169809323000004 |
|
Q2 2023
|
37 |
228,000 |
NOTE, CD, HOLI, SIMO
|
13F-HR
|
8/14/2023 |
000169809323000003 |
|
Q1 2023
|
36 |
150,581 |
NOTE, SOHU, YY, BILIBILI INC
|
13F-HR
|
5/11/2023 |
000169809323000002 |
|
Q4 2022
|
42 |
275,980 |
NOTE, FISCALNOTE HOLDINGS INC, YY, SOHU
|
13F-HR
|
2/13/2023 |
000169809323000001 |
|
Q3 2022
|
2 |
167,883 |
NOTE, FISCALNOTE HOLDINGS INC
|
NEW HOLDINGS
|
11/15/2022 |
000169809322000006 |
|
Q3 2022
|
56 |
231,560 |
NOTE, YY, SOHU, JOYY INC
|
13F-HR
|
11/14/2022 |
000169809322000004 |
|
Q3 2022
|
2 |
29,337 |
NOTE, FISCALNOTE HOLDINGS INC
|
NEW HOLDINGS
|
11/14/2022 |
000169809322000005 |
|
Q2 2022
|
61 |
177,206 |
DSAC, COHR, YY, SOHU
|
13F-HR
|
8/15/2022 |
000169809322000003 |
|
Q1 2022
|
56 |
245,872 |
JOBS, DSAC, NEW FRONTIER HEALTH CORP, YY
|
13F-HR
|
5/16/2022 |
000169809322000002 |
|
Q4 2021
|
47 |
217,642 |
DSAC, NEW FRONTIER HEALTH CORP, JOBS, YY
|
13F-HR
|
2/14/2022 |
000169809322000001 |
|
Q3 2021
|
41 |
221,973 |
JOBS, DSAC, NEW FRONTIER HEALTH CORP, YY
|
13F-HR
|
11/15/2021 |
000169809321000004 |
|
Q2 2021
|
54 |
304,431 |
JOBS, New Frontier Health Corp, DSAC, YY
|
13F-HR
|
8/16/2021 |
000169809321000003 |
|
Q1 2021
|
47 |
259,515 |
CHINA BIOLOGIC PRODUCTS INC, DSAC, New Frontier Health Corp, GNW
|
13F-HR
|
5/17/2021 |
000169809321000002 |
|
Q4 2020
|
45 |
366,585 |
SINA, CHINA BIOLOGIC PRODUCTS INC, DSAC, GNW
|
13F-HR
|
2/12/2021 |
000169809321000001 |
|
Q3 2020
|
21 |
178,899 |
CHINA BIOLOGIC PRODUCTS INC, GNW, ACIA, SINA
|
13F-HR
|
11/12/2020 |
000169809320000007 |
|
Q2 2020
|
22 |
247,871 |
CHINA BIOLOGIC PRODUCTS INC, BITA, WUBA, GNW
|
13F-HR
|
8/14/2020 |
000169809320000005 |
|
Q1 2020
|
21 |
386,086 |
AGN, CHINA BIOLOGIC PRODUCTS INC, BITA, CHANGYOU.COM LTD
|
13F-HR
|
5/11/2020 |
000169809320000004 |
|
Q4 2019
|
20 |
310,961 |
AGN, CHINA BIOLOGIC PRODS HLDGS INC, BITA, CHANGYOU COM LTD
|
13F-HR
|
2/12/2020 |
000169809320000003 |
|
Q3 2019
|
19 |
278,342 |
CELG, BPL, CHINA BIOLOGIC PRODS HLDGS I, BITA
|
13F-HR
|
11/14/2019 |
000169809319000007 |
|
Q2 2019
|
19 |
190,659 |
CELG, RHT, BPL, CHINA BIOLOGIC PRODS HLDGS I
|
13F-HR
|
8/13/2019 |
000169809319000006 |
|
Q1 2019
|
16 |
145,461 |
BMS, RHT, CELG, CHINA BIOLOGIC PRODS HLDGS I
|
13F-HR
|
5/14/2019 |
000169809319000004 |
|
Q4 2018
|
10 |
79,638 |
SPDR S&P 500 ETF TR calls, CHINA BIOLOGIC PRODS HLDGS I, GNW, YUMC
|
13F-HR
|
2/14/2019 |
000169809319000001 |
|
Q3 2018
|
12 |
102,682 |
SPDR S&P 500 ETF TR calls, BUNGE LIMITED calls, CHINA BIOLOGIC PRODS HLDGS I, YUMC
|
13F-HR
|
11/14/2018 |
000169809318000004 |
|
Q2 2018
|
24 |
176,286 |
KANG, BUNGE LIMITED calls, NXPI, NXP SEMICONDUCTORS N V calls
|
13F-HR
|
8/13/2018 |
000169809318000003 |
|
Q1 2018
|
18 |
115,195 |
KANG, NXPI, BUNGE LIMITED calls, BG
|
13F-HR
|
5/14/2018 |
000169809318000002 |
|
Q4 2017
|
14 |
82,313 |
KANG, NXPI, AXTA, CHANGYOU COM LTD
|
13F-HR
|
2/9/2018 |
000169809318000001 |
|
Q3 2017
|
17 |
138,272 |
POWERSHARES QQQ TRUST puts, POWERSHARES QQQ TRUST calls, KANG, NXPI
|
13F-HR
|
11/13/2017 |
000169809317000010 |
|
Q2 2017
|
10 |
75,488 |
ZPIN, KANG, NXPI, GENWORTH FINL INC puts
|
13F-HR
|
8/14/2017 |
000169809317000009 |
|
Q1 2017
|
7 |
49,772 |
KANG, MOMO INC calls, 0A2P.IL, IKANG HEALTHCARE GROUP INC calls
|
13F-HR
|
5/15/2017 |
000169809317000003 |
|
Q4 2016
|
5 |
29,826 |
KANG, 0A2P.IL, SINA, MOMO
|
13F-HR
|
2/14/2017 |
000169809317000002 |